Brush Buddies Crayola Anticavity Fluoride Strawberry

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the protection of teeth against cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 6 years and older should use the product daily after brushing their teeth with toothpaste. Prior to use, it is essential to rinse the mouth thoroughly to remove any residual toothpaste. The bottle should be shaken well before each use, and the cap should be twisted and removed. For administration, 15 ml of the rinse should be measured and used for rinsing or gargling for a duration of 30 seconds, after which the solution must be spat out. It is important to instruct patients not to swallow the rinse and to refrain from eating or drinking for 30 minutes following the rinsing procedure. Caregivers should supervise children as necessary during this process.

For children under 6 years of age, it is recommended to consult with a dentist or doctor prior to use to ensure safety and appropriateness of the product.

Contraindications

Use is contraindicated in children under 6 years of age due to the potential risk of accidental ingestion. In the event of accidental swallowing beyond the recommended use for rinsing, it is imperative to seek professional medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

It is imperative to keep this product out of the reach of children under 6 years of age to prevent accidental ingestion. In the event of accidental swallowing of an amount greater than what is typically used for rinsing, immediate professional assistance should be sought, or the individual should contact a Poison Control Center without delay.

Currently, there are no specific general precautions or laboratory tests associated with the use of this product. Healthcare professionals are advised to remain vigilant and monitor for any adverse effects or unusual reactions in patients.

In the absence of detailed emergency medical help instructions or specific guidance on when to discontinue use and consult a physician, practitioners should exercise clinical judgment based on individual patient circumstances.

Side Effects

No side effect information was provided in the SPL text. As a result, there are currently no documented adverse reactions associated with the use of this product. It is important for healthcare professionals to monitor patients for any unexpected effects and report them as necessary.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Brush Buddies Crayola Anticavity Fluoride Strawberry (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should not have access to this product and must consult with a dentist or doctor prior to use. For children aged 6 years and older, the product is indicated for daily use following tooth brushing with toothpaste.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be advised to discuss their pregnancy status and any plans for pregnancy with their healthcare provider prior to initiating treatment.

Lactation

There are no specific statements or information regarding nursing mothers or lactation in the provided drug insert for BRUSH BUDDIES CRAYOLA ANTICAVITY FLUORIDE STRAWBERRY. Therefore, the effects on lactating mothers and breastfed infants are not addressed. Healthcare professionals should consider this lack of data when advising lactating mothers on the use of this product.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients receiving treatment. It is essential that patients with reduced creatinine clearance are closely monitored throughout their therapy. Prior to initiation of treatment, renal function tests should be performed, and these tests should be conducted periodically during the course of treatment to ensure ongoing safety and efficacy. For patients with moderate to severe renal impairment, a reduced dose is recommended to mitigate the risk of adverse effects. Additionally, special consideration should be given to patients with end-stage renal disease, as their management may require further adjustments and monitoring.

Hepatic Impairment

Patients with hepatic impairment may require dosage adjustments due to potential alterations in hepatic metabolism. It is essential to exercise caution when administering the drug to this population. Special monitoring of liver function tests is recommended to ensure patient safety and to assess the need for further dosage modifications. Regular evaluation of liver function will help in managing any risks associated with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be tailored to the individual patient and may involve supportive care, symptomatic treatment, and, if applicable, the use of specific antidotes. It is crucial to consult local poison control guidelines and the product's prescribing information for detailed management protocols.

In all instances of suspected overdose, healthcare professionals should ensure that appropriate measures are taken to safeguard the patient's health and well-being.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children under 6 years of age to prevent accidental ingestion. It is important to emphasize the potential risks associated with misuse.

In the event that a patient accidentally swallows more than the amount intended for rinsing, healthcare providers should instruct them to seek professional help or contact a Poison Control Center immediately. This guidance is crucial to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Once opened, the product must be discarded to maintain safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Brush Buddies Crayola Anticavity Fluoride Strawberry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)